Showing results (41-50 of 241) with videos related to
Sort By:
Pageof 25
International Immunopharmacology|August 30, 2003
Flow cytometric mapping of the leukotriene B4 receptor, BLT1, in human bone marrow and peripheral blood using specific monoclonal antibodiesAnnika Pettersson, Johan Richter, Christer OwmanBrain Sciences|May 27, 2023
Combined Use of Frameless Neuronavigation and In Situ Optical Guidance in Brain Tumor Needle BiopsiesElisabeth Klint, Johan Richter, Karin WårdellMicrocirculation (New York, N.Y. : 1994)|September 28, 2024
Cerebral Microcirculation: Progress and Outlook of Laser Doppler Flowmetry in Neurosurgery and Neurointensive CareKarin Wårdell, Johan Richter, Peter ZsigmondBiochemical and Biophysical Research Communications|December 18, 2007
Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemiaManu Gupta, Lili Milani, Monica Hermansson, et al.Haematologica|January 29, 2008
Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemiaTuija Lundán, Vesa Juvonen, Martin C Mueller, et al.Haematologica|November 4, 2005
The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemiaIngrid Thörn, Ulla Olsson-Strömberg, Cecilia Ohlsen, et al.Experimental Hematology|July 31, 2012
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemiaAnna Kreutzman, Taina Jaatinen, Dario Greco, et al.British Journal of Haematology|February 5, 2008
Towards a better understanding and new therapeutics of osteopetrosisMaria K Askmyr, Anders Fasth, Johan RichterBlood|March 7, 2009
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet StudyMichele Baccarani, Gianantonio Rosti, Fausto Castagnetti, et al.Immunology|June 4, 2010
T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignanciesCamilla A Lindqvist, Lisa H Christiansson, Bengt Simonsson, et al.Pageof 25